A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
Clinical trial NCT06220773 · UNKNOWN
Trial details
- NCT number
- NCT06220773
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2025-04-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.